| | |
SHASUN-PHARMACEUTICALS-FALLS:Shasun Pharmaceuticals falls on Vertex drug warning
Reuters Market Eye - Shasun Pharmaceuticals
Shasun has a long-term agreement with Vertex for supply of active pharmaceutical ingredient for the Hepatitis C drug.
"There would be incremental impact on Shasun as about 25 percent of FY13 profits were expected to come in from Incivek supply," said Surya Patra, an analyst tracking the sector at Systematix Shares & Stocks.
(Reporting by Abhishek Vishnoi)
ADS BY GOOGLE
video of the day
Tepid Q4 shows market frail on valuations: Kotaks Prasad